Target type: biologicalprocess
The orderly movement of an intestinal epithelial cell from one site to another, often during the development of a multicellular organism. [GOC:dph]
Intestinal epithelial cell migration is a complex and highly regulated process essential for maintaining the integrity of the intestinal lining. It plays a crucial role in wound healing, tissue repair, and normal epithelial turnover. Here's a detailed breakdown of the process:
1. **Initiation:** Migration is triggered by various stimuli, including:
* **Growth factors:** Epidermal growth factor (EGF), transforming growth factor-α (TGF-α), hepatocyte growth factor (HGF), and fibroblast growth factor (FGF) stimulate cell proliferation and migration.
* **Cytokines:** Interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) can trigger migration in response to injury or inflammation.
* **Extracellular matrix (ECM) components:** Integrins, cell surface receptors, bind to ECM proteins like fibronectin and laminin, initiating intracellular signaling cascades that regulate migration.
2. **Cell Polarization:** The migrating cell undergoes a dramatic change in its morphology, becoming polarized with distinct front and rear regions:
* **Leading edge:** The front of the cell extends protrusions called lamellipodia and filopodia. Lamellipodia are sheet-like extensions rich in actin filaments, providing the driving force for movement. Filopodia are thin, finger-like projections that explore the environment and sense chemoattractant signals.
* **Trailing edge:** The rear of the cell forms a stable structure called the uropod, anchoring the cell and facilitating detachment from the substrate.
3. **Motility:** The cell moves forward by a coordinated process of:
* **Protrusion:** Actin polymerization at the leading edge drives lamellipodia extension, pushing the cell membrane forward.
* **Adhesion:** Integrins at the leading edge bind to ECM proteins, forming temporary attachments that anchor the cell.
* **Contraction:** Myosin motor proteins interact with actin filaments, generating contractile forces that pull the cell body forward.
* **Detachment:** At the trailing edge, integrin-ECM interactions are broken, allowing the cell to detach and move forward.
4. **Regulation:** Intestinal epithelial cell migration is tightly controlled by intracellular signaling pathways:
* **Rho GTPases:** These small GTP-binding proteins play crucial roles in regulating actin polymerization, cell adhesion, and migration direction.
* **PI3K/Akt pathway:** This pathway promotes cell survival, proliferation, and migration by activating downstream targets.
* **MAPK signaling:** Mitogen-activated protein kinases (MAPKs) are involved in regulating cell proliferation, differentiation, and migration.
* **Calcium signaling:** Calcium ions act as second messengers, modulating cytoskeletal dynamics and cell motility.
5. **Consequences of Impaired Migration:** Defects in intestinal epithelial cell migration can lead to:
* **Delayed wound healing:** Impaired migration slows down the repair of intestinal lesions, increasing the risk of infections and complications.
* **Inflammatory bowel disease:** Dysregulated migration contributes to chronic inflammation and tissue damage in diseases like Crohn's disease and ulcerative colitis.
* **Cancer metastasis:** Cancer cells exploit migration pathways to spread to distant sites, leading to secondary tumors.
6. **Future Directions:** Further research is ongoing to understand the intricate molecular mechanisms underlying intestinal epithelial cell migration. This knowledge could lead to novel therapeutic strategies for treating intestinal diseases and preventing cancer metastasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Tyrosine-protein phosphatase non-receptor type 11 | A tyrosine-protein phosphatase non-receptor type 11 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q06124] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
glycyrrhetinic acid | cyclic terpene ketone; hydroxy monocarboxylic acid; pentacyclic triterpenoid | immunomodulator; plant metabolite | |
oxanilic acid | oxanilic acid: RN given refers to parent cpd; structure | ||
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
phosphotyrosine | O(4)-phospho-L-tyrosine : A non-proteinogenic L-alpha-amino acid that is L-tyrosine phosphorylated at the phenolic hydroxy group. Phosphotyrosine: An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid; O(4)-phosphotyrosine | Escherichia coli metabolite; immunogen |
vanadates | vanadate(3-) : A vanadium oxoanion that is a trianion with formula VO4 in which the vanadium is in the +5 oxidation state and is attached to four oxygen atoms. Vanadates: Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects. | trivalent inorganic anion; vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
4-methylumbelliferyl phosphate | |||
maslinic acid | (2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoria | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite |
nsc-87877 | NSC-87877: potent Shp2 (nonreceptor protein tyrosine phosphatase) inhibitor; structure in first source | ||
tingenone | tingenone: quinonoid triterpene isolated from Euonymus tingens | ||
geniposide | terpene glycoside | ||
tanshinone | tanshinone: from root of Salvia miltiorrhiza Bunge; RN given refers to tanshinone I; cardioprotective agent and neuroprotective agent | abietane diterpenoid | anticoronaviral agent |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
cryptotanshinone | cryptotanshinone: from Salvia miltiorrhiza | abietane diterpenoid | anticoronaviral agent |
tanshinone ii a | tashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first source | abietane diterpenoid | |
nsc-89199 | estramustine phosphate : A steroid phosphate which is the 17-O-phospho derivative of estramustine. | carbamate ester; organochlorine compound; steroid phosphate | |
estramustine | estramustine : A carbamate ester obtained by the formal condensation of the hydroxy group of 17beta-estradiol with the carboxy group of bis(2-chloroethyl)carbamic acid. Estramustine: A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. | 17beta-hydroxy steroid; carbamate ester; organochlorine compound | alkylating agent; antineoplastic agent; radiation protective agent |
genipin | iridoid monoterpenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cross-linking reagent; hepatotoxic agent; uncoupling protein inhibitor | |
cefsulodin | cefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. | cephalosporin; organosulfonic acid; primary carboxamide | antibacterial drug |
nsc 117199 | |||
illudalic acid | illudalic acid: isolated from Clitocybe illudens; structure in first source | ||
2-amino-6-chloropurine | 6-chloroguanine : An organochlorine compound that is 7H-purin-2-amine substituted by a chloro group at position 6. 6-chloroguanine: an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase; structure in first source | 2-aminopurines; organochlorine compound | |
4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid | |||
Dihydrotanshinone I | dihydrotanshinone I: extracted from Radix Salviae | abietane diterpenoid | anticoronaviral agent |
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid | 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source |